J Kevin Buchi is Director of Ampio Pharmaceuticals, Inc.. Currently has a direct ownership of 146,858 shares of AMPE, which is worth approximately $0. The most recent transaction as insider was on Jun 09, 2023, when has been sold 21,858 shares (Common Stock) at a price of $0.29 per share, resulting in proceeds of $6,338. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 147K
0% 3M change
0% 12M change
Total Value Held $0

J KEVIN BUCHI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2023
BUY
Open market or private purchase
$6,338 $0.29 p/Share
21,858 Added 12.96%
146,858 Common Stock
Jun 08 2023
BUY
Open market or private purchase
$7,500 $0.3 p/Share
25,000 Added 16.67%
125,000 Common Stock
May 16 2023
BUY
Open market or private purchase
$8,784 $0.27 p/Share
32,534 Added 24.55%
100,000 Common Stock
May 15 2023
BUY
Open market or private purchase
$11,006 $0.25 p/Share
44,026 Added 39.49%
67,466 Common Stock
May 12 2023
BUY
Open market or private purchase
$5,625 $0.24 p/Share
23,440 Added 50.0%
23,440 Common Stock

Also insider at

AMRX
Amneal Pharmaceuticals, Inc. Healthcare
BNTC
Benitec Biopharma Inc. Healthcare
TCRT
Alaunos Therapeutics, Inc. Healthcare
DRNA
Dicerna Pharmaceuticals Inc
JKB

J Kevin Buchi

Director
Boston, MA

Track Institutional and Insider Activities on AMPE

Follow Ampio Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPE shares.

Notify only if

Insider Trading

Get notified when an Ampio Pharmaceuticals, Inc. insider buys or sells AMPE shares.

Notify only if

News

Receive news related to Ampio Pharmaceuticals, Inc.

Track Activities on AMPE